News|Articles|August 24, 2026

National Psoriasis Awareness Month 2026: More Oral Options, Wider Access, and a Systemic Lens

Author(s)Marie Bosslett, Assistant Editor

New trials show oral psoriasis drugs rival biologics, expand care across ages, and spotlight systemic risks—plus the ongoing fight for access. Read our exclusive recap for PsO Action Month.

Psoriasis Awareness Month lands this year amid a wave of trial readouts and clinical commentary that, taken together, point to a field in transition. Oral therapies are closing in on the efficacy once reserved for injectable biologics, treatment is expanding to younger and older patients, and specialists are increasingly framing psoriasis as a systemic disease that extends well beyond the skin.